2'-C-Methyl analogues of selective adenosine receptor agonists: Synthesis and binding studies

Journal of Medicinal Chemistry

Volumn 41, Issue 10, 1998, Pages 1708-1715

  Franchetti, Palmarisa ^a   Cappellacci, Loredana ^a   Marchetti, Stefano ^a   Trincavelli, Letizia ^b   Martini, Claudia ^b   Mazzoni, Maria R ^b   Lucacchini, Antonio ^b   Grifantini, Mario ^a  

^a UNIVERSITY OF CAMERINO   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2 CHLORO 2' C METHYL N6 CYCLOPENTYLADENOSINE; 6 N CYCLOPENTYLADENOSINE; ADENOSINE 5' CYCLOPENTYLADENOSINE; ADENOSINE RECEPTOR STIMULATING AGENT; ADENYLATE CYCLASE; UNCLASSIFIED DRUG;

ARTICLE; BRAIN MEMBRANE; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; ENZYME ACTIVATION; RECEPTOR AFFINITY; RECEPTOR DENSITY; TESTIS; TISSUE DISTRIBUTION;

ADENOSINE; ADENOSINE-5'-(N-ETHYLCARBOXAMIDE); ADENYLATE CYCLASE; ANIMALS; BRAIN; CATTLE; ENZYME INHIBITORS; MALE; MEMBRANES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ADENOSINE A2A; RECEPTOR, ADENOSINE A3; RECEPTORS, PURINERGIC P1; TESTIS;

EID: 0032492932     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm9707737     Document Type: Article

References (22)

1. Jacobson, K, A., Daly, J. W., Manganiello, V., Eds. Purines in Cellular Signaling -Targets for New Drugs; Springer-Verlag: New York, 1990.
2. 2 Receptors: Structure-Function Relationships. Med. Res. Rev. 1992, 12, 423-471.
3. Jacobson, K. A.; Van Galen, P. J. M.; Williams, M. Adenosine Receptors -Pharmacology, Structure Activity Relationships, and Therapeutic Potential. J. Med. Chem. 1992, 35, 407-422.
4. von Lubitz, D. K. J. E.; Jacobson, K. A. Behavioral Effects of Adenosine Receptor Stimulation, In Adenosine and Adenine Nucleotides: From Molecular Biology to Integrative Physiology; Belardinelli, L., Pelleg, A., Eds.; Kluwer: Norwell, MA, 1995; pp 489-498.
5. Jacobson, M. Cloning and Expression of Human Adenosine Receptor Subtypes. In Adenosine and Adenine Nucleotides: From Molecular Biology to Integrative Physiology; Belardinelli, L., Pelleg, A., Eds.; Kluwer: Norwell, MA, 1995; pp 5-13.
6. Daly, J. W.; Jacobson, K. A. Adenosine Receptors: Selective Agonists and Antagonists. In Adenosine and Adenine Nucleotides: From Molecular Biology to Integrative Physiology; Belardinelli, L., Pelleg, A., Eds.; Kluwer: Norwell, MA, 1995; pp 157-166.
7. 3 Adenosine Receptors. J. Med. Chem. 1994, 37, 3614-3621.
8. Siddiqi, S. M.; Jacobson, K. A.; Esker, J. L.; Olah, M. E.; Ji, X.- d.; Melman, N.; Tiwari, K. N.; Secrist, III; J. A., Schneller, S. W.; Cristalli, G.; Stiles, G. L.; Johnson, C. R.; IJzerman, A. P. Search for New Purine- and Ribose-Modified Adenosine Analogues as Selective Agonists and Antagonists at Adenosine Receptors. J. Med. Chem. 1995, 38, 1174-1188.
9. Wolfe, M. S.; Harry-O'Tuiru, R. E. A Concise Synthesis of 2′-CMethyl-ribonucleosides. Tetrahedron Lett. 1995, 36, 7611-7614.
10. Prasad, B. N.; Banana, D. S.; Fung, A.; Savic, M.; Tietje, K.; Stein, H. H.; Brondyk, H.; Egan, R. S. Modification of the 5′ Position of Purine Nucleosides. 2. Synthesis and Some Cardiovascular Properties of Adenosine-5′-(Af-substituted)carboxam- : ides. J. Med. Chem. 1980, 23, 313-319.
11. Rosemeyer, H.; Toth, G.; Golankiewicz, B.; Kazimierczuk, Z.; Burgeois, W.; Kretschmer, U.; Muth, H.-P.; Seela, F. Syn-Anti Conformational Analysis of Regular and Modified Nucleosides by ID 1H NOE Difference Spectroscopy: a Simple Graphical Method Based on Conformationally Rigid Molecules. J. Org. Chem. 1990, 55, 5784-5790.
12. (a) Martini, C.; Pennacchi, E.; Poli, M. G.; Lucacchini, A. Solubilization of adenosine AI binding sites from sheep cortex. Neurochem. Int. 1985, 7, 1017-1020.
13. 2+ Ion. Biochim. Biophys. Acta 1993, 1220, 76-84.
14. 6substituted Adenosine Derivatives in Rat Testis Membranes J. Recept. Sign. Transd. Res. 1995, 15, 905-929.
15. Zhou, Q. Y.; Chuanyu, L. I.; Olah, M. E.; Johnson, R. A.; Stiles, G. L.; Civelli, O. Molecular Cloning and Characterization of an Adenosine Receptor: the AS Adenosine Receptor. Proc. Natl. Acad. Sci. U.S.A. 1992, 59, 7432-7436.
16. Nutt, R. F.; Dickinson, M. J.; Holly, F. W.; Walton, E. BranchedChain Sugar Nucleosides. V. Synthesis and Antiviral Properties of Several Branched-Chain Sugar Nucleosides. J. Org. Chem. 1968, 33, 1789-1759.
17. Kalinichenko, E. N.; Beigel'man, L. N.; Mikhailov, S. N.; Mikhailopulo, I. A. Substrate specificity of adenosine deaminase: role of methyl groups at 2′-, 3′- and 5′-positions of adenosine. Biorg. Khim. 1988, 14, 1157-1161 and references therein.
18. Bruns, R. F. Adenosine Antagonism by Purines, Pteridines and Benzopteridines in Human Fibroblasts. Biochem. Pharmacol. 1981, 30, 325-333.
19. Lupica, C. R.; Cass, W. A.; Zahniser, N. R.; Dunwiddie, T. V. Effects of the Selective Adenosine A2 Receptor Agonist CGS 21680 on in vitro Electrophysiology, cAMP Formation and Dopamine Release in Rat Hippocampus and Striatum. J. Pharmacol. Exp. Ther. 1995, 252, 1134-1141.
20. Walton, E.; Jenkins, S. R.; Nutt, R. F.; Zimmerman, M.; Holly, F. W. Branched-Chain Sugar Nucleosides. A New Type of Biologically Active Nucleoside. J. Am. Chem. Soc. 1966, 88, 4524-4525.
21. 50) of an Enzyme Reaction. Biochem. Pharmacol. 1973, 22, 3099-3108.
22. Johnson, R. G.; Alvarez, R.; Salomon, Y. Determination of Adenylyl Cyclase Catalytic Activity Using Single and Double Column Procedures. Methods Enzymol. 1994, 238, 31-56.